Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study

Fig. 2

CTCs detection rate at 4 timepoints: 1) baseline; 2) after neoadjuvant androgen deprivation therapy; 3) at the end of radiotherapy; and 4) 6–12 months after the end of radiotherapy in those patients with 0 CTCs in the first determination and a change to positive CTCs in the following determinations. CTC, circulating tumor cell; ADT, androgen deprivation therapy

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us